Category Trading
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SBHIX | 29.21 | 0.28 | +0.97% |
| Saratoga Health & Biotechnology I | |||
| GQJPX | 12.86 | 0.08 | +0.63% |
| GQG Partners Intl Qual Val Fd Inv | |||
| GRMRX | 33.94 | 0.15 | +0.44% |
| Nationwide S&P 500 Index R | |||
| PLGIX | 16.46 | 0.07 | +0.43% |
| Principal LargeCap Growth I Instl | |||
| TNRAX | 23.07 | 0.09 | +0.40% |
| 1290 Avantis U.S. Large Cap Growth A | |||
BEX saw its Momentum Indicator move below the 0 level on August 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 12 similar instances where the indicator turned negative. In of the 12 cases, the stock moved further down in the following days. The odds of a decline are at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BEX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BEX entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for BEX just turned positive on August 03, 2026. Looking at past instances where BEX's MACD turned positive, the stock continued to rise in of 5 cases over the following month. The odds of a continued upward trend are .
Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where BEX advanced for three days, in of 41 cases, the price rose further within the following month. The odds of a continued upward trend are .